nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0412	0.0412	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0355	0.0355	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0348	0.0348	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.034	0.034	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0303	0.0303	CbGpPWpGaD
Nebivolol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0296	0.0296	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0294	0.0294	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.029	0.029	CbGpPWpGaD
Nebivolol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0288	0.0288	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0281	0.0281	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0274	0.0274	CbGpPWpGaD
Nebivolol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0268	0.0268	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0262	0.0262	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0255	0.0255	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0249	0.0249	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0247	0.0247	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0244	0.0244	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0242	0.0242	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0237	0.0237	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.023	0.023	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0225	0.0225	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.022	0.022	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0192	0.0192	CbGpPWpGaD
Nebivolol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0188	0.0188	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0184	0.0184	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0161	0.0161	CbGpPWpGaD
Nebivolol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.016	0.016	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0158	0.0158	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0154	0.0154	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0132	0.0132	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0128	0.0128	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00834	0.00834	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00603	0.00603	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00585	0.00585	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00585	0.00585	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00572	0.00572	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00568	0.00568	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00559	0.00559	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00555	0.00555	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00545	0.00545	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00543	0.00543	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0053	0.0053	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00529	0.00529	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00517	0.00517	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00506	0.00506	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00501	0.00501	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0049	0.0049	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00486	0.00486	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00479	0.00479	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00476	0.00476	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00465	0.00465	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00453	0.00453	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00443	0.00443	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00433	0.00433	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00382	0.00382	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00373	0.00373	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0037	0.0037	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0037	0.0037	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00365	0.00365	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00362	0.00362	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00362	0.00362	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00354	0.00354	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00354	0.00354	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00345	0.00345	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00338	0.00338	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0033	0.0033	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00317	0.00317	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0031	0.0031	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00304	0.00304	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00242	0.00242	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00236	0.00236	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00231	0.00231	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00216	0.00216	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00211	0.00211	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00209	0.00209	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00206	0.00206	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00205	0.00205	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.002	0.002	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00196	0.00196	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00195	0.00195	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00192	0.00192	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00191	0.00191	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0019	0.0019	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00186	0.00186	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00182	0.00182	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00179	0.00179	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00177	0.00177	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00173	0.00173	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00169	0.00169	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00137	0.00137	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00134	0.00134	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00131	0.00131	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00124	0.00124	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00121	0.00121	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00119	0.00119	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00116	0.00116	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00113	0.00113	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00112	0.00112	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00111	0.00111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0011	0.0011	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00107	0.00107	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00105	0.00105	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00102	0.00102	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.001	0.001	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000733	0.000733	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000717	0.000717	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000701	0.000701	CbGpPWpGaD
